A rare disease is that which affects a small percentage of a given population. It is also known as an orphan disease in some countries and its rareness is linked to scarcity of resources and support that is needed to develop effective treatment plans. Lack or insufficient access to knowledge about these conditions within Kenyan communities results in adverse effects on health and general wellbeing.
MHS has partnered with an international Lab, Centogene, to help identify, diagnose and provide effective treatment plans for our genetic clients. We have set a working system that ensures experts analyze the results and they are translated to the ‘common mwananchi’ in the simplest terms for them to understand.
